Lupin launches generic immunosuppressant capsules in US

Lupin launches generic immunosuppressant capsules in US As per IQVIA MAT August 2019 data, Mycophenolate Mofetil capsules USP, 250 mg, had annual sales of around $ 53 million in the US, Lupin said.

No comments:

Post a Comment